Oman inflation inches up by 0.56% in March

Non-hydrocarbon activities are expected to account for 70.5 percent of this total, reflecting progress in the country’s Vision 2040 goals. File
Short Url
Updated 04 May 2025
Follow

Oman inflation inches up by 0.56% in March

RIYADH: Oman’s inflation rate inched up by 0.56 percent in March, reflecting overall price stability despite notable movements in select consumer categories, official data showed. 

According to data from the National Centre for Statistics and Information, the biggest year-on-year gain was recorded in the miscellaneous goods and services segment, which rose 6.11 percent, followed by health, up 3.22 percent, and transport, which advanced 1.74 percent.  

In contrast, prices for vegetables and fish and seafood fell sharply, declining 10.23 percent and 6.95 percent, respectively. 

Oman’s inflation remains one of the lowest in the region, thanks to government measures, prudent fiscal policies, high oil prices, and rising non-oil exports, with the rate easing in recent months. 

Across the region, Saudi Arabia recorded a 2.3 percent annual rise in consumer prices in March, with inflation largely driven by housing and utility costs, while Dubai’s rate moderated to 2.8 percent, down from 3.15 percent in February, supported by lower transport and food costs. 

On a monthly basis, Oman’s general index dropped by 0.36 percent in March compared to February.    

Despite the decline, the fruit category saw a 3.25 percent increase, followed by the miscellaneous goods and services group which saw a 0.72 percent increase.   

In contrast, transport prices fell 1.86 percent month on month, while the fish and seafood group dropped 3.53 percent.  

The food and beverages category, which holds the highest weighting in the consumer price index basket, fell 0.74 percent year on year and 0.58 percent month on month.   

Within this group, milk, cheese and eggs posted a 2.97 percent annual increase, while bread and cereals and meat fell by 0.55 percent and 0.44 percent, respectively.  

Oman has continued to consolidate its fiscal position, building on the momentum of recent surpluses. 

The Ministry of Finance recently reaffirmed its 2025 budget outlook, underpinned by sustained oil revenue and ongoing diversification initiatives. 

The sultanate recorded a real gross domestic growth of 1.3 percent in 2023, supported by a robust non-oil sector, and projects GDP to reach 44.1 billion Omani rial ($114.66 billion) in 2025.  

Non-hydrocarbon activities are expected to account for 70.5 percent of this total, reflecting progress in the country’s Vision 2040 goals. 

Additionally, public revenues are projected at 11.2 billion rial, with a continued focus on reducing public debt and boosting private sector participation. 


Saudi-French cooperation to localize veterinary vaccine manufacturing

Updated 17 February 2026
Follow

Saudi-French cooperation to localize veterinary vaccine manufacturing

RIYADH: In the presence of sector leaders, the National Livestock and Fisheries Development Program signed a memorandum of understanding with French company Ceva under the patronage of Minister of Environment, Water and Agriculture Abdulrahman bin Abdulmohsen Al-Fadhli, who also chairs the program’s board.

The agreement aims to localize vaccine manufacturing, transfer technology and technical expertise, and expand the industrial and commercial production of veterinary vaccines across the Kingdom.

According to the MoU, the two parties will work to achieve high efficiency in mass production scale-up and establish a clear path for sustainable commercial operation that meets the needs of the local and national market, as well as strengthen the biosecurity and food security system.

The MoU also includes the development and modernization of messenger RNA vaccine technologies, along with joint research and development of a Middle East Respiratory Syndrome vaccine for camels. This involves designing, evaluating, and developing vaccines specifically tailored to combat the virus.

The agreement also covers the development of a rabies vaccine and related solutions, as well as supporting national efforts to control the disease through vaccine provision, capacity building, and the implementation of integrated prevention strategies.

The collaboration between the program and Ceva aims to meet the needs of the poultry vaccine market in the Kingdom, currently estimated at around SR750 million ($199 million).

The company will work to cover approximately 30 percent of this market with an initial investment of around SR250 million.

With continued government support for poultry projects and increased production in the sector, the market is expected to grow at a rate exceeding 10 percent annually, reaching approximately SR1.25 billion by 2030.

The addition of the world’s leading poultry vaccine manufacturer to Biotech Park highlights the program’s key role in developing new industries within the livestock and fisheries sector.

It also highlights the program’s commitment to building international partnerships with global companies, organizations, research centers, and universities to support advanced biotechnology industries and attract high-quality investments. It also seeks to create new economic sectors based on biotechnology, enhance veterinary health security, and support the sustainable economic development of the livestock sector, as well as empower national and emerging companies and provide advanced research and industrial infrastructure.

This will solidify the Kingdom’s position as a global hub for biotechnology industries and the development of national capabilities.

Ceva is the first international partner to join Biotech Park, the future veterinary biotechnology city launched by the program in Dhurma Governorate. The city is the world’s first specialized and fully integrated hub for veterinary biotechnology, serving as a benchmark for sector development and a platform supporting markets across the Kingdom, the Gulf, the Middle East, Africa and beyond.

The signing of Ceva is a significant step, given its position as the world’s leading manufacturer of poultry vaccines and medicines, and one of the most prominent international companies in the field of biotechnology.

The MoU aims to localize the veterinary vaccine industry, ensuring its compatibility with the strains of poultry diseases prevalent in Saudi Arabia. This includes the transfer of technology and technical expertise from Ceva, along with the implementation of specialized training programs to guarantee that manufacturing facilities comply with international Good Manufacturing Practice standards.